Table 5 shows the hazard ratios (HRs) for age, sex, body mass index, smoking status, cerebrovascular disease, coronary artery disease, hypertension, systolic and diastolic blood pressures, diabetes mellitus, fasting glucose, log-transformed triglyceride, total cholesterol, hemoglobin, baseline CKD stage, total calcium, phosphorous, calcium-phosphorous product, uric acid, PTH, log-transformed UPCR, ACEI/ARB antihypertensive drug and calcium-based phosphate binders use, and quartiles of UPCR (model 1) or log-transformed UPCR (model 2). This evidence concerns the gene PTH and chronic kidney disease.